24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Divestment
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:14
Unknown investor, expanding arsenal: Ondas buys four defense firms in days
13:09
Mystery-funded defense firm Ondas expands Israeli buying spree with Bird Aerosystems acquisition at $133 million valuation
10:52
$260,000 Porsche at heart of legal fight over marriage and money
10:31
"Ensuring the hits": The frontline feedback behind Smart Shooter's fire control tech
More stories
Buzz
Most popular
Daily
Weekly
1
Israel orders airborne laser system for fighter jets and helicopters
2
AWS veterans raise $31 million Series A for cyber startup Native to simplify multi-cloud security
3
Palo Alto founder Nir Zuk sells digital bank Esh to Isracard at $130 million valuation
4
Israeli startup Thermagix claims “the only economical solution for harvesting low-grade heat”
5
After Symantec exit, Javelin founders raise $20 million for new cyber bet Raven
More news
Divestment
8 stories about Divestment
Norwegian wealth fund divests from Israel’s banking sector
26.08.25
|
CTech
Four largest banks targeted for financing settlements; Caterpillar shares also sold.
Norway’s sovereign fund expands Israeli divestments amid Gaza war scrutiny
18.08.25
|
CTech, Reuters
Since late June, the fund has sold shares in 17 Israeli companies, including Paz, Azorim, Delek Motors, El Al, Energix, eToro, Max Stock, Levinsky Engineering, Priortech, Rami Levy, REIT 1, Retailors, Sela Real Estate, Amos Luzon Group Development and Energy, Firon, and Scope Metals.
With No Buyers, Teva to Close Israeli Medical Equipment Plant
09.04.18
|
Dror Reich
The facility in Ashdod is one of five Teva intends to sell or close in its home country
Allergan to Sell Teva Shares to J.P. Morgan
14.11.17
|
Dror Reich and Lilach Baumer
Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018
Teva Offloads Holdings in Australia’s Mesoblast
25.10.17
|
Dror Reich and Lilach Baumer
The stem-cell therapy company diluted Teva’s shares through a new offering in August
Founding Family Sells Holdings in Online Gambling Company 888
09.10.17
|
Golan Hazani and Lilach Baumer
Co-founder Aaron Shaked’s heirs sold their entire stake for nearly $300 million
Teva Sells Remaining Women's Health Assets
18.09.17
|
Lilach Baumer
After selling its Paragard business for $1.1 billion last week, Teva's remaining Women's Health business will be split between CVC Capital Partners and Foundation Consumer Healthcare in a $1.38 billion cash deal
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says
14.09.17
|
Lilach Baumer
CVC Capital Partners is nearing a $800 million deal for Teva's remaining Women's Health business, Bloomberg reported Thursday